XyloCor Therapeutics
Latest funding:$67.5M · Series B (January 7, 2025)
Angel investors who backed XyloCor Therapeutics
23 investors in our database backed XyloCor Therapeutics.
James H.
Board Member
Jonathan Leff
Executive Partner
Maha Katabi, PhD, CFA
General Partner
Hooman Shahlavi
Chief Legal Officer
Anne Portwich
Board Member
Nathalie Auber
Partner and CFO
Joachim Rothe
Partner
Rene Kuijten
Partner, head of EQT Life Sciences (formerly LSP), member EQT Private Capital management team
Sarah Bhagat
Biotech Advisor
Merijn Klaassen
CFO & COO
Perry Nisen
Independent Director, Chair of Science and Technology
Mark Wegter
Partner
Drew Burdon
Board Member
Rudy Dekeyser
Member Board of Directors
Martijn Kleijwegt
Managing Partner
David Kabakoff
Executive Partner, Private Equity
Regina Salvat
Associate, Private Equity
Alfred Yue
Vice President Finance
Christoph Westphal
Founder and General Partner
Rich Aldrich
Venture Partner
James Mutamba
Principal
John Lawrence
CFO
Lea Hachigian
Principal
Who invested in...
See every angel investor and VC behind well-known startups.
Find the right investors for your startup
Search thousands of angel investors and VCs by industry, stage, check size, and location — and see who backed companies like XyloCor Therapeutics.
Search investors